- Methodological Review of Cost Effectiveness Analysis of Cancer Screening
-
Jung KT
- KMID: 2304040
- Korean J Epidemiol.
- 1998 Jun;20(1):13-31.
The role of economic evaluation for medical services can be summarixed as providing objective criteria for rational bgudget allocation. With medical and epidemiologial studies, cost effectiveness analysis of cancer screening... -
- CITED
-
- Close
- SHARE
-
- Close
- HCV self-testing: Bridging screening gaps and ensuring cost-effectiveness for both high-risk and universal populations: Correspondence to editorial on “Self-testing strategy to eliminate hepatitis C as per World Health Organization’s goal: Analysis of disease burden and cost-effectiveness”
-
Shin G, Kim BK, Bae S, Lee H, Ahn SH
- KMID: 2567014
- Clin Mol Hepatol.
- 2025 Apr;31(2):e163-e165.
- doi: 10.3350/cmh.2024.1057
-
- CITED
-
- Close
- SHARE
-
- Close
- Universal self-testing as a cost-effective weapon to eliminate hepatitis C virus in the Republic of Korea: Editorial on “Self-testing strategy to eliminate hepatitis C as per World Health Organization’s goal: Analysis of disease burden and cost-effectiveness”
-
Jang ES
- KMID: 2566982
- Clin Mol Hepatol.
- 2025 Apr;31(2):596-598.
- doi: 10.3350/cmh.2024.0992
-
- CITED
-
- Close
- SHARE
-
- Close
- Cost-effectiveness of tisotumab vedotin as a second- or third-line therapy for cervical cancer
-
Huo G, Liu W, Chen P
- KMID: 2564947
- J Gynecol Oncol.
- 2024 Sep;35(5):e58.
- doi: 10.3802/jgo.2024.35.e58
Objective: To evaluate the cost-effectiveness of tisotumab vedotin to treat recurrent or metastatic cervical cancer in second- or third-line from the U.S. payer perspective. Methods: A Markov model with three-state was... -
- CITED
-
- Close
- SHARE
-
- Close
- Cost-Effectiveness Analysis of Immunotherapy in Patient with Allergic Rhinitis
-
Park JY, Kim YS, Kim JK, Cho JH
- KMID: 2519753
- Korean J Otorhinolaryngol-Head Neck Surg.
- 2021 Aug;64(8):554-562.
- doi: 10.3342/kjorl-hns.2020.00752
Background and Objectives All treatments must be effective and affordable. Although it is clear that immunotherapy is effective in patients with allergic rhinitis, no cost-effectiveness analysis has been conducted in... -
- CITED
-
- Close
- SHARE
-
- Close
- Cost-Effectiveness Analysis of Germline and Somatic BRCA Testing in Patients With Advanced Ovarian Cancer
-
Jang J, Kim Y, Kim JH, Cho SM, Lee KA
- KMID: 2551588
- Ann Lab Med.
- 2023 Jan;43(1):73-81.
- doi: 10.3343/alm.2023.43.1.73
Background: BRCA testing is necessary for establishing a management strategy for ovarian cancer. Several BRCA testing strategies, including germline and somatic testing, are implemented in clinical practice in Korea. We... -
- CITED
-
- Close
- SHARE
-
- Close
- The Concept of Economic Evaluation and Its Application in Thyroid Cancer Research
-
Kim K, Kim M, Lim W, Kim BH, Park SK
- KMID: 2519660
- Endocrinol Metab.
- 2021 Aug;36(4):725-736.
- doi: 10.3803/EnM.2021.1164
Economic evaluation is a type of comparative analysis between interventions in terms of both their resource use and health outcomes. Due to the good prognosis of thyroid cancer (TC), the... -
- CITED
-
- Close
- SHARE
-
- Close
- Cost-Effectiveness Estimate for Neural Monitoring in Thyroid Surgery
-
Kim HY, Chai YJ, Freni F, Makay O, Galletti B, Galletti F, Sun H, Dionigi G, The Korean Intraoperative Neural Monitoring Society (KINMoS)
- KMID: 2414419
- J Endocr Surg.
- 2018 Mar;18(1):10-20.
- doi: 10.16956/jes.2018.18.1.10
There is growing evidence for the importance of more detailed cost evaluation of new technologies used in surgery. The innovative impact of technology holds the potential to achieve transformative clinical... -
- CITED
-
- Close
- SHARE
-
- Close
- Cost-Utility Analysis of Non-Contrast Abbreviated Magnetic Resonance Imaging for Hepatocellular Carcinoma Surveillance in Cirrhosis
-
Decharatanachart P, Pan-ngum W, Peeraphatdit T, Tanpowpong N, Tangkijvanich P, Treeprasertsuk S, Rerknimitr R, Chaiteerakij R
- KMID: 2551043
- Gut Liver.
- 2024 Jan;18(1):135-146.
- doi: 10.5009/gnl230089
Background/Aims: Ultrasonography has a low sensitivity for detecting early-stage hepatocellular carcinoma (HCC) in cirrhotic patients. Non-contrast abbreviated magnetic resonance imaging (aMRI) demonstrated a comparable performance to that of magnetic resonance... -
- CITED
-
- Close
- SHARE
-
- Close
- Cost-Effectiveness of Recombinant Tissue Plasminogen Activator in the Management of Acute Ischemic Stroke: A Systematic Review
-
Jung KT, Shin DW, Lee KJ, Oh M
- KMID: 1462847
- J Clin Neurol.
- 2010 Sep;6(3):117-126.
- doi: 10.3988/jcn.2010.6.3.117
BACKGROUND AND PURPOSE: This work was undertaken to review the current cost-effectiveness analysis data on thrombolysis by intravenous (IV) therapy with recombinant tissue plasminogen activator (rtPA) for acute ischemic stroke. METHODS:... -
- CITED
-
- Close
- SHARE
-
- Close
- Cost-effectiveness analysis of low density lipoprotein cholesterol-lowering therapy in hypertensive patients with type 2 diabetes in Korea: single-pill regimen (amlodipine/atorvastatin) versus double-pill regimen (amlodipine+atorvastatin)
-
Park JH, Lee YH, Ko SK, Cha BS
- KMID: 2380647
- Epidemiol Health.
- 2015;37:e2015010.
- doi: 10.4178/epih/e2015010
OBJECTIVES: Single-pill combination therapy (amlodipine/atorvastatin) might be more effective than double-pill therapy (amlodipine+atorvastatin) in patients with diabetes and concomitant hypertension requiring statin therapy. We compared the cost-effectiveness of a single-pill... -
- CITED
-
- Close
- SHARE
-
- Close
- Cost-Effectiveness of Hearing Aids in South Korea: A Multistate Markov Model Analysis
-
Oh H, Yoon CY, Lee J, Seo YJ, Chung W, Park MK
- KMID: 2569688
- Clin Exp Otorhinolaryngol.
- 2025 May;18(2):143-151.
- doi: 10.21053/ceo.2024.00255
Objectives. This study evaluated the cost-effectiveness of using hearing aids among individuals aged 50 and older with varying levels of hearing loss in South Korea. Methods. A state-transition Markov model was... -
- CITED
-
- Close
- SHARE
-
- Close
- Immunotherapy plus chemotherapy in patients with advanced endometrial cancer: a cost-effectiveness analysis
-
Zhu Y, Liu K, Zhu H
- KMID: 2565451
- J Gynecol Oncol.
- 2025 Jan;36(1):e6.
- doi: 10.3802/jgo.2025.36.e6
Objective: Pembrolizumab and dostarlimab are immune checkpoint inhibitors that target programmed death receptor 1 (PD-1). Combination anti-PD-1 regimens have been shown to exhibit favorable survival benefits when treating advanced endometrial... -
- CITED
-
- Close
- SHARE
-
- Close
- Cost-Utility Analysis of Early Detection with Ultrasonography of Differentiated Thyroid Cancer: A Retrospective Study on a Korean Population
-
Baek HS, Ha J, Kim K, Bae JS, Kim JS, Kim S, Lim DJ, Kim CM
- KMID: 2554636
- Endocrinol Metab.
- 2024 Apr;39(2):310-323.
- doi: 10.3803/EnM.2023.1870
Background: There is debate about ultrasonography screening for thyroid cancer and its cost-effectiveness. This study aimed to evaluate the cost-effectiveness of early screening (ES) versus symptomatic detection (SD) for differentiated... -
- CITED
-
- Close
- SHARE
-
- Close
- Cost-effectiveness analysis of single-dose or 2-dose of bivalent, quadrivalent, or nonavalent HPV vaccine in a low/middle-income country setting
-
Termrungruanglert W, Khemapech N, Vasuratna A, Havanond P, Tantitamit T
- KMID: 2564977
- J Gynecol Oncol.
- 2024 Nov;35(6):e85.
- doi: 10.3802/jgo.2024.35.e85
Objective: To compare the health impact and economic benefits among individuals who did not receive the human papillomavirus (HPV) vaccine to those who received a single dose, or 2 doses.... -
- CITED
-
- Close
- SHARE
-
- Close
- Olaparib plus bevacizumab as a first-line maintenance treatment for patients with advanced ovarian cancer by molecular status: an updated PAOLA-1 based cost-effectiveness analysis
-
Zhu Y, Yang Q, Liu K, Cao H, Zhu H
- KMID: 2564860
- J Gynecol Oncol.
- 2024 Jan;35(1):e2.
- doi: 10.3802/jgo.2024.35.e2
Objective: The PAOLA-1 trial (NCT02477644) reported final survival benefit associated with olaparib plus bevacizumab maintenance treatment of patients with advanced ovarian cancer (AOC) based on molecular status. Our aimed to... -
- CITED
-
- Close
- SHARE
-
- Close
- Cost-Effectiveness of Voluntary HIV Testing Strategies in a Very Low-Prevalence Country, the Republic of Korea
-
Lee YH, Bang JH, Park SM, Kang CR, Cho SI, Oh MD, Lee JK
- KMID: 2432129
- J Korean Med Sci.
- 2018 Nov;33(46):e304.
- doi: 10.3346/jkms.2018.33.e304
BACKGROUND: The Republic of Korea has a very low prevalence of human immunodeficiency virus (HIV) infection, but the number of new HIV diagnoses has steadily risen, strongly indicating a large... -
- CITED
-
- Close
- SHARE
-
- Close
- Cost-Effectiveness of Denosumab for Post-Menopausal Osteoporosis in South Korea
-
Bae G, Kwon HY
- KMID: 2416672
- Korean J Clin Pharm.
- 2018 Jun;28(2):131-137.
- doi: 10.24304/kjcp.2018.28.2.131
BACKGROUND: In South Korea, 22.3% of women ≥50 years of age and 37% of women ≥70 years of age visit the doctor to obtain treatment for osteoporosis. According to the... -
- CITED
-
- Close
- SHARE
-
- Close
- Cost analysis of hypertension screening program
-
Park EC, Yu SH
- KMID: 2282440
- Korean J Prev Med.
- 1989 Sep;22(3):380-388.
To evaluate the costs the hypertension screening program of the Korea Medical Insurance Corporation, the records of the screening examinations were used. The sample size was 49,983 of the 906,554... -
- CITED
-
- Close
- SHARE
-
- Close
- A Model-Based Cost-Effectiveness Analysis of Long-Acting Monoclonal Antibody (Tixagevimab and Cilgavimab: Evusheld) Preventive Treatment for High-Risk Populations Against SARSCoV-2 in Korea
-
Jo Y, Kim SB, Jung J
- KMID: 2545202
- J Korean Med Sci.
- 2023 Aug;38(32):e250.
- doi: 10.3346/jkms.2023.38.e250
Background: Tixagevimab and cilgavimab (Evusheld) administration is a recommended strategy for unvaccinated patients with immunocompromised conditions and severe allergic reaction conditions to protect high-risk individuals and control the coronavirus disease... -
- CITED
-
- Close
- SHARE
-
- Close
